Enterprise Value

1.118B

Cash

652M

Avg Qtr Burn

N/A

Short % of Float

17.45%

Insider Ownership

0.24%

Institutional Own.

92.94%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
MVC-COV1901 Details
COVID-19 Vaccine

Approved

Update

Heplisav-B Details
Infectious disease, Hepatitis B vaccine, Hepatitis B

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Phase 2

Data readout

Phase 1/2

Initiation

VLA2001 Details
Infectious disease, COVID-19

Failed

Discontinued